| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Phathom Pharmaceuticals Inc (NASDAQ: PHAT)
PHAT Technical Analysis
2
| As on 9th Jun 2023 PHAT STOCK Price closed @ 12.99 and we RECOMMEND Buy for LONG-TERM with Stoploss of 11.96 & Strong Sell for SHORT-TERM with Stoploss of 17.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHATSTOCK Price
| Open | 12.37 | Change | Price | % |
| High | 13.49 | 1 Day | 0.69 | 5.61 |
| Low | 12.21 | 1 Week | 1.23 | 10.46 |
| Close | 12.99 | 1 Month | 2.77 | 27.10 |
| Volume | 370500 | 1 Year | -6.37 | -32.90 |
| 52 Week High 20.06 | 52 Week Low 6.19 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PHAT Daily Charts |
PHAT Intraday Charts |
Whats New @ Bazaartrend |
PHAT Free Analysis |
|
|
PHAT Important Levels Intraday
| RESISTANCE | 15.46 |
| RESISTANCE | 14.67 |
| RESISTANCE | 14.18 |
| RESISTANCE | 13.69 |
| SUPPORT | 12.29 |
| SUPPORT | 11.80 |
| SUPPORT | 11.31 |
| SUPPORT | 10.52 |
PHAT Forecast May 2024
| 4th UP Forecast | 24.38 |
| 3rd UP Forecast | 20.73 |
| 2nd UP Forecast | 18.47 |
| 1st UP Forecast | 16.21 |
| 1st DOWN Forecast | 9.77 |
| 2nd DOWN Forecast | 7.51 |
| 3rd DOWN Forecast | 5.25 |
| 4th DOWN Forecast | 1.6 |
PHAT Weekly Forecast
| 4th UP Forecast | 15.98 |
| 3rd UP Forecast | 15.02 |
| 2nd UP Forecast | 14.43 |
| 1st UP Forecast | 13.83 |
| 1st DOWN Forecast | 12.15 |
| 2nd DOWN Forecast | 11.55 |
| 3rd DOWN Forecast | 10.96 |
| 4th DOWN Forecast | 10.00 |
PHAT Forecast2024
| 4th UP Forecast | 40.85 |
| 3rd UP Forecast | 31.92 |
| 2nd UP Forecast | 26.39 |
| 1st UP Forecast | 20.87 |
| 1st DOWN Forecast | 5.11 |
| 2nd DOWN Forecast | -0.41 |
| 3rd DOWN Forecast | -5.94 |
| 4th DOWN Forecast | -14.87 |
Phathom Pharmaceuticals Inc ( NASDAQ USA Symbol : PHAT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHAT Business Profile
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey. Address: 100 Campus Drive, Florham Park, NJ, United States, 07932
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service